Idalopirdine, a 5-HT6 receptor antagonist in development for the treatment of mild-moderate Alzheimer’s disease: the scientific rationale
de Jong, Inge, Herrik, Kjartan, Helboe, Lone, Foraster, Maria Amat, Smagin, Gennady, Leiser, Steven, Ferris, Craig, Mørk, ArneVolume:
39
Language:
english
Journal:
Neurobiology of Aging
DOI:
10.1016/j.neurobiolaging.2016.01.059
Date:
March, 2016
File:
PDF, 52 KB
english, 2016